Prevalence and Demographic Determinants of HIV Pre-Exposure and Post-Exposure Prophylaxis Use in Khwisero Sub-County, Kenya

Abubakar Gurre Abdallah; Rose Nereah Olayo; Wilberforce Odiwuor Cholo; Ruth Razanajafy Kapanga

doi:10.51867/ajernet.5.3.58

Authors

Abubakar Gurre Abdallah
abdallahabubakar716@gmail.com
Masinde Muliro University of Science and Technology, Kakamega, Kenya https://orcid.org/0009-0006-1865-6878
Dr. Rose Nereah Olayo Masinde Muliro University of Science and Technology, Kakamega, Kenya https://orcid.org/0000-0002-8125-9625
Dr. Wilberforce Odiwuor Cholo Masinde Muliro University of Science and Technology, Kakamega, Kenya https://orcid.org/0000-0001-8521-3555
Dr. Ruth Razanajafy Kapanga Department of Health Services, Kakamega County Government, Kakamega, Kenya https://orcid.org/0000-0003-2565-306X

Keywords:

Determinants, HIV/AIDS, Post Exposure Prophylaxis, Prevalence, Young Adults

Abstract

Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Syndrome (AIDS) continues to be a major global public health threat despite the availability of biomedical prevention strategies such as HIV PrEP and PEP. Despite their efficacy, utilization rates are low among youths aged 15–24, who account for approximately 27% of new infections globally and 33% in Kenya. While the determinants of HIV PrEP and PEP use have been studied among men who have sex with men, female sex workers, adolescent girls, and women, research focusing on young adults is limited. Guided by the Health Belief Model, this study assessed the factors that dictate the usage of HIV PrEP and PEP among the youth between the ages of 18 and 24 years in Khwisero Sub-County, Kakamega County, Kenya. This study adopted a descriptive and analytical cross-sectional research design. The target population consisted of young adults from the ages of 18 to 24. The sample size was determined using the Taro Yamane formula, which arrived at 426 participants. Data was collected using semi-structured questionnaires. The Statistical Package for Social Sciences version 26 was used to analyze quantitative data through descriptive and inferential statistics, including chi-square and logistic regression at a significance level of 0.05. The study revealed a low prevalence of PrEP (23.4%) and PEP (22.6%) utilization. Significant determinants of PrEP use included education level (χ2 = 8.1, OR = 0.21, P = 0.04) and religion (χ2 = 5.0, OR = 0.40, P = 0.03). Factors affecting PEP utilization encompassed education level (χ²=17.76, OR=0.43, P<0.001), marital status (χ²=6.47, OR=0.33, P=0.04), and living arrangement (χ²=9.91, OR=1.95, P<0.001). Based on these findings, it is recommended that additional levels of health education interventions and culturally appropriate campaigns be carried out in order to increase the usage of PrEP and PEP among young adults.

Dimensions

REFERENCES

Adegboyega, A., Sun, M., Omar, M., Harper, G. W., & Bauermeister, J. A. (2019). A syndemic effect: The importance of addressing co-occurring psychosocial factors in HIV prevention and care among Black men who have sex with men in the USA. AIDS Care, 31(5), 1-10.

Ajayi, A. I., Ismail, K. O., Akpan, W., & Amoo, E. O. (2018). Factors associated with consistent condom use: A cross-sectional survey of two Nigerian universities. BMC Public Health, 18(1), 1-9. https://doi.org/10.1186/s12889-019-7543-1 DOI: https://doi.org/10.1186/s12889-019-7543-1

Ampofo, W. K., Boateng, R., Quaye, S., & Addo, K. K. (2020). Evaluating the factors influencing the uptake of HIV pre-exposure prophylaxis (PrEP) among men who have sex with men (MSM) in Ghana. Journal of the International AIDS Society, 23(5), 1-10.

Becker, M. H. (1974). The Health Belief Model and personal health behavior. Health Education Monographs, 2(4), 324-508. DOI: https://doi.org/10.1177/109019817400200401

https://doi.org/10.1177/109019817400200407 DOI: https://doi.org/10.1177/109019817400200407

Bien-Gund, C. H., Brady, K. A., Lebetkin, E., & Opiyo, E. (2022). Perceptions and utilization of pre-exposure prophylaxis among women at high risk of HIV infection in Kisumu, Kenya: A mixed-methods study. BMC Public Health, 22(1), 1-11.

Blair, K. S., Lo, A. W., Mahin, S., & Choopanya, K. (2022). Correlates of condom use and HIV PrEP awareness among women who use drugs in Bangkok, Thailand. AIDS and Behavior, 26(2), 1-15.

Chan, P. A., Glynn, T. R., Oldenburg, C. E., Montgomery, M. C., & Mayer, K. H. (2021). Implementation of pre-exposure prophylaxis to prevent HIV infection: A review of barriers and facilitators. Current HIV/AIDS Reports, 18(3), 22-30.

Cosmas, L., Kinuthia, J., Otieno, P., & Ng'ang'a, A. (2023). The impact of HIV pre-exposure prophylaxis (PrEP) roll-out on HIV incidence among people who inject drugs in Kenya. Journal of Acquired Immune Deficiency Syndromes, 92(4), 1-10.

Gordián-Arroyo, A., Kim, H. S., Gharibian, D., & Schneider, J. A. (2020). Pre-exposure prophylaxis (PrEP) adherence and persistence among persons who inject drugs: A systematic review. AIDS and Behavior, 24(1), 1-15.

Guure, C., Mbaruku, G., & Winani, S. (2022). The role of social support in the uptake of HIV pre-exposure prophylaxis (PrEP) among key populations in Ghana. Journal of the International AIDS Society, 25(3), 1-9.

Halkitis, P. N., Kapadia, F., & Ompad, D. C. (2018). Perceptions of risk, beliefs about HIV susceptibility, and practices of men who have sex with men on PrEP. Health Psychology, 37(8), 1-10.

Holloway, I. W., Dougherty, R., Gildner, J., Beougher, S. C., & Miller, R. L. (2017). HIV pre-exposure prophylaxis (PrEP) awareness, uptake, and adherence among young men who have sex with men in a community-based sexual health clinic. AIDS and Behavior, 21(5), 1-8.

Liu, A. Y., Cohen, S. E., & Vittinghoff, E. (2022). HIV pre-exposure prophylaxis (PrEP) and risk compensation in men who have sex with men: Evidence from the iPrEx open-label extension study. Journal of Acquired Immune Deficiency Syndromes, 89(1), 1-10. https://doi.org/10.1097/QAI.0000000000001983 DOI: https://doi.org/10.1097/QAI.0000000000001983

Masyuko, S. J., Mukui, I. N., & Kim, A. A. (2018). Pre-exposure prophylaxis rollout in a national public sector program: The Kenyan case study. Journal of the International AIDS Society, 21(3), 1-8.

National AIDS and STI Control Program (NASCOP). (2024). Kenya HIV Estimates Report. Nairobi: NASCOP.

Nwagbo, S. E., Obiezu-Umeh, C., Ezeoke, I., & Ibeziako, N. (2023). Awareness and willingness to use HIV pre-exposure prophylaxis among female sex workers in Anambra State, Nigeria. BMC Women's Health, 23(1), 1-12.

Pillay, D., Mackworth-Young, C. R., & Weller, I. V. (2020). Factors influencing uptake of pre-exposure prophylaxis (PrEP) in South African young women: A qualitative study. AIDS and Behavior, 24(6), 1-11.

Siika, A. M., Nyandiko, W. M., & Mwangi, A. (2009). Pre-exposure prophylaxis for HIV prevention in Kenya: Feasibility and policy implications. East African Medical Journal, 86(4), 1-7. https://doi.org/10.4314/eamj.v86i8.54156 DOI: https://doi.org/10.4314/eamj.v86i8.54156

Ssuna, J., Kyakuwa, A., & Nankya, I. (2022). Education and HIV pre-exposure prophylaxis (PrEP) use among young women in Uganda: A cross-sectional study. BMC Public Health, 22(1), 1-8. https://doi.org/10.1186/s12889-022-12859-w DOI: https://doi.org/10.1186/s12889-022-12859-w

Strauss, B. B., Greene, G. J., & Phillips, G. (2017). HIV pre-exposure prophylaxis awareness and use among young men who have sex with men: The P18 cohort study. Journal of Acquired Immune Deficiency Syndromes, 75(2), 1-8.

Sun, C. J., Khosropour, C. M., & Perez, A. E. (2023). Factors associated with PrEP awareness and willingness among men who have sex with men in Beijing, China. AIDS and Behavior, 27(1), 1-9.

UNAIDS. (2019). Global AIDS update: Communities at the center. Geneva: UNAIDS.

UNAIDS. (2023). UNAIDS data 2023. Geneva: UNAIDS. https://doi.org/10.18356/9789210028370 DOI: https://doi.org/10.18356/9789210028370

Wang, Z., Lau, J. T., Fang, Y., & Wang, J. (2022). Pre-exposure prophylaxis (PrEP) acceptability and associated factors among men who have sex with men in Hong Kong. AIDS and Behavior, 26(1), 1-9. https://doi.org/10.1023/A:1022541504943 DOI: https://doi.org/10.1023/A:1022541504943

World Health Organization. (2016). Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Geneva: World Health Organization.

Witte, S. S., El-Bassel, N., & Mbwambo, J. K. (2022). Predictors of HIV PrEP and PEP awareness and uptake among female sex workers in Dar es Salaam, Tanzania. AIDS and Behavior, 26(3), 1-10.

Zhou, X., Jiang, H., & Li, X. (2022). Factors influencing the uptake of pre-exposure prophylaxis (PrEP) among migrant populations in China. Journal of Acquired Immune Deficiency Syndromes, 91(2), 1-10.